Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The CD47 "don't eat me signal" is highly expressed in human ovarian cancer.
Gynecol Oncol. 2016 Nov;143(2):393-397. doi: 10.1016/j.ygyno.2016.08.325. Epub 2016 Aug 25.
Gynecol Oncol. 2016.
PMID: 27569584
Free PMC article.
Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator.
Grzankowski KS, Brightwell RM, Kasznica JM, Odusi KO.
Grzankowski KS, et al. Among authors: brightwell rm.
Gynecol Oncol Rep. 2014 Nov 17;11:10-2. doi: 10.1016/j.gore.2014.11.002. eCollection 2015 Jan.
Gynecol Oncol Rep. 2014.
PMID: 26076085
Free PMC article.
Item in Clipboard
Poorly differentiated Sertoli-Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report.
Brightwell R, Grzankowski K, Kasznica J, Frederick PJ.
Brightwell R, et al.
Gynecol Oncol Rep. 2015 Aug 13;14:6-8. doi: 10.1016/j.gore.2015.08.001. eCollection 2015 Nov.
Gynecol Oncol Rep. 2015.
PMID: 26793762
Free PMC article.
Item in Clipboard
Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
Kolomeyevskaya NV, Szender JB, Zirpoli G, Minlikeeva A, Friel G, Cannioto RA, Brightwell RM, Grzankowski KS, Moysich KB.
Kolomeyevskaya NV, et al. Among authors: brightwell rm.
Int J Gynecol Cancer. 2015 Nov;25(9):1587-92. doi: 10.1097/IGC.0000000000000540.
Int J Gynecol Cancer. 2015.
PMID: 26273932
Free PMC article.
Item in Clipboard
Higher than expected frequencies of non-ovarian cancers within a large familial ovarian cancer registry.
Brightwell RM, Grzankowski KS, Kaur J, Poblete S, Miller A, Lele SB, Sucheston-Campbell L, Moysich K, Odunsi KO.
Brightwell RM, et al.
Am J Clin Exp Obstet Gynecol. 2015;2(1):39-44. Epub 2015 Feb 15.
Am J Clin Exp Obstet Gynecol. 2015.
PMID: 26605374
Free PMC article.
Item in Clipboard
Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients.
Brightwell R, Eng K, Lele S.
Brightwell R, et al.
Eur J Gynaecol Oncol. 2017;38(3):378-381.
Eur J Gynaecol Oncol. 2017.
PMID: 29693877
Item in Clipboard
Docetaxel and nab-paclitaxel are safe alternative options for patients with gynecologic malignancies following hypersensitivity reaction to paclitaxel.
Brightwell R, Handel E, Eng K, Grzankowski K, Frederick P, Odunsi K, Lele S.
Brightwell R, et al.
Eur J Gynaecol Oncol. 2016;37(6):800-802.
Eur J Gynaecol Oncol. 2016.
PMID: 29943924
Item in Clipboard
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.
Tanner EJ, Long KC, Zhou Q, Brightwell RM, Gardner GJ, Abu-Rustum NR, Leitao MM Jr, Sonoda Y, Barakat RR, Iasonos A, Chi DS.
Tanner EJ, et al. Among authors: brightwell rm.
Gynecol Oncol. 2012 Jul;126(1):58-63. doi: 10.1016/j.ygyno.2012.04.014. Epub 2012 Apr 13.
Gynecol Oncol. 2012.
PMID: 22507533
Free PMC article.
Item in Clipboard
Cite
Cite